Celldex Therapeutics, Inc. (CLDX) Earnings
NASDAQ·Healthcare·Biotechnology
$30.18
+2.31%
Mkt Cap $2.30B
EPS — Estimate vs Actual
Mkt Cap
$2.30B
P/E
—
Fwd P/E
—
P/S
2801.21
Rev TTM
—
EPS TTM
-$4.27
NASDAQ·Healthcare·Biotechnology
$30.18
+2.31%
Mkt Cap $2.30B
Mkt Cap
$2.30B
P/E
—
Fwd P/E
—
P/S
2801.21
Rev TTM
—
EPS TTM
-$4.27